Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva reaches $4.25 billion settlement over alleged role in opioid crisis - CBS News
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva CEO Richard Francis on Q2 earnings beat - YouTube
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - KTSA
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
What does Teva's growth strategy look like?
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to court | US News | Sky News
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
